4:15 Long COVID care cuts could hurt patients who need it most A recently released study suggests that fluvoxamine, a low‑cost and widely available antidepressant, “significantly improved fatigue and ...

A global research team co‑led by McMaster University has identified one of the first medications shown to meaningfully reduce fatigue in people living with long COVID—a breakthrough for millions still ...

Vitamin D supplements may offer researchers a new clue about lingering COVID symptoms that persist after infection, according to a new study. Researchers at Mass General Brigham examined whether high ...

JPMorgan Chase common stock has slipped in 2026, impacted by a high valuation and lower interest rates, which may weigh on its net interest income. I continue to believe covered calls present the best ...

Authors of an editorial commentary in Clinical Infectious Diseases reviewed evidence from randomized trials and real-world analyses to evaluate why metformin should be offered to adults with COVID-19 ...

A common drug may be able to cure a common illness. Around one in four people have developed long-haul symptoms of COVID-19, experiencing fatigue, brain fog, chronic cough, chest pain and more for ...

A massive international study of more than 3,100 long COVID patients uncovered a striking divide in how brain-related symptoms are reported around the world. In the U.S., the vast majority of ...

To crush long distances (think half marathons and marathons), you don’t just need a solid training plan. You need a certain level of grit—and by grit, we mean you must be willing to show up to your ...

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. Why are we so ill-prepared for the common ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. government shut down much of its operations just after midnight on Wednesday, Oct. 1 as Congress and the White House ...